Dihydroartemisinin (DHA) exhibits almighty anti-malarial and anti-cancer activities. This abstraction aimed to investigate the anti-proliferative furnishings of a aggregate of DHA and doxorubicin (DOX) on animal breast blight cells.
In a analytical analysis of randomized controlled trials, both dihydroartemisinin-piperaquine and artemether-lumefantrine are actual able at alleviative malaria (high superior evidence). However, dihydroartemisinin-piperaquine cures hardly added patients than artemether-lumefantrine, and it aswell prevents added malaria infections for best afterwards analysis (high superior evidence). Dihydroartemisinin-piperaquine and artemether-lumefantrine apparently accept agnate ancillary furnishings (moderate superior evidence). The studies were all conducted in Africa. In studies of humans active in Asia, dihydroartemisinin-piperaquine is as able as artesunate additional mefloquine at alleviative malaria (moderate superior evidence). Artesunate additional mefloquine apparently causes added nausea, vomiting, dizziness, sleeplessness, and palpitations than dihydroartemisinin-piperaquine (moderate superior evidence).